Alvesco has not been shown to cause the typical side effects of other inhaled steroids. There is no evidence that Alvesco causes thrush, which may be an added benefit for people prone to developing this common yeast infection of the mouth. There appears to be no effect on the growth of children using Alvesco, which is often a major concern for parents of asthmatic children using inhaled steroids. In fact, Alvesco has no known whole-body steroid effects, including no increased risk for glaucoma, cataract formation, osteoporosis or Cushing syndrome.
Finally, since Alvesco is indicated for the treatment of mild to moderate persistent asthma in adults and children 12 years and older with once-daily dosing, compliance with this medication should be better than with other asthma inhalers that require dosing multiple times a day. If you think that Alvesco may be a good treatment option for your or your child’s asthma, see your physician today.
Find out more about Alvesco.
Sources:
Skoner DP, et al. Assessment of the long-term safety of inhaled ciclesonide on growth in children with asthma. Pediatrics. 2008;121(1):e1-14.
Pearlman DS, et al. Once-daily ciclesonide improves lung function
and is well tolerated by patients with mild-to-moderate
persistent asthma. J Allergy Clin Immunol 2005;116:1206-12.
DISCLAIMER: The information contained in this site is for educational purposes only, and should not be used as a substitute for personal care by a licensed physician. Please see your physician for diagnosis and treatment of any concerning symptoms or medical condition.
